Patent details

Basic Information

Publication number:

EP3431086

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP181933128

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NOVEL ANTI-INFLAMMATORY AGENTS

French Title of Invention:

NOUVEAUX AGENTS ANTI-INFLAMMATOIRES

German Title of Invention:

NEUARTIGE ENTZÜNDUNGSHEMMENDE MITTEL

SPC Number:

Dates

Filing date:

21/04/2010

Grant date:

17/06/2020

EP Publication Date:

23/01/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/06/2020

EP B1 Publication Date:

17/06/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/04/2021

Expiration date:

21/04/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/06/2020

 

 

Name:

Resverlogix Corp.

Address:

300, 4820 Richard Road SW, Calgary, AB T3E 6L1, Canada (CA)

Inventor

1

Name:

ATTWELL, Sarah, C.

Address:

Canada (CA)

2

Name:

HANSEN, Henrik, C.

Address:

Canada (CA)

3

Name:

MCLURE, Kevin, G.

Address:

Canada (CA)

4

Name:

KULIKOWSKI, Ewelina, B.

Address:

Canada (CA)

5

Name:

WAGNER, Gregory, S.

Address:

United States (US)

Priority

Priority Number:

171620 P

Priority Date:

22/04/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/47; C07D 239/91;

Publication

European Patent Bulletin

Issue number:

202025

Publication date:

17/06/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages